Slow Capital, Inc. Repligen Corp Transaction History

Slow Capital, Inc.

$645 Million
Q3 2024

A detailed history of Slow Capital, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Slow Capital, Inc. holds 16,226 shares of RGEN stock, worth $2.33 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

16,226

Previous 16,165 0.38%

Holding current value

$2.33 Million

Previous $2.04 Million 18.51%

% of portfolio

0.37%

Previous 0.33%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$119.79 - $167.35 $7,307 - $10,208	61 Added 0.38%	16,226 $2.41 Million
Q2 2024 Jul 24, 2024	BUY	$120.0 - $182.95 $186,960 - $285,036	1,558 Added 10.67%	16,165 $2.04 Million
Q1 2024 Apr 17, 2024	BUY	$170.78 - $208.42 $59,431 - $72,530	348 Added 2.44%	14,607 $2.69 Million
Q4 2023 Jan 30, 2024	BUY	$114.17 - $185.35 $30,483 - $49,488	267 Added 1.91%	14,259 $2.56 Million
Q3 2023 Oct 19, 2023	BUY	$138.78 - $176.51 $308,507 - $392,381	2,223 Added 18.89%	13,992 $2.22 Million
Q2 2023 Aug 09, 2023	SELL	$138.42 - $180.31 $46,785 - $60,944	-338 Reduced 2.79%	11,769 $1.66 Million
Q1 2023 Apr 26, 2023	BUY	$154.26 - $198.1 $55,842 - $71,712	362 Added 3.08%	12,107 $2.04 Million
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $119,378 - $162,111	735 Added 6.68%	11,745 $1.99 Million
Q3 2022 Oct 27, 2022	BUY	$160.42 - $256.21 $1,283 - $2,049	8 Added 0.07%	11,010 $2.06 Million
Q2 2022 Jul 28, 2022	BUY	$140.68 - $188.02 $1.55 Million - $2.07 Million	11,002 New	11,002 $1.79 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.98B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Slow Capital, Inc. with notifications on news.

Account